Last reviewed · How we verify
Loceryl 5%
At a glance
| Generic name | Loceryl 5% |
|---|---|
| Sponsor | Oystershell NV |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- CLINICAL INVESTIGATION FOR THE EVALUATION OF EFFICACY AND SAFETY OF TWO PRODUCTS FOR THE TREATMENT OF ONYCHOMYCOSIS (NA)
- Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis (NA)
- Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment (NA)
- Antifungal Activity of Loceryl Nail Lacquer in Combination With a Cosmetic Varnish (PHASE4)
- Comparison Between Long-pulsed Nd:YAG, Amorolfine and Combination Treatment in Treating Non-dermatophyte Onychomycosis (PHASE4)
- Clinical Evaluation of Efficacy and Safety of a Medical Device for the Treatment of Toenail Onychomycosis (NA)
- Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus Ciclopirox Nail Lacquer (PHASE4)
- Treatment of Onychomycosis With Loceryl (Amorolfine) Nail Lacquer 5% Versus a Two-course Treatment With Urea 40% Ointment and Bifonazole Cream 1% (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Loceryl 5% CI brief — competitive landscape report
- Loceryl 5% updates RSS · CI watch RSS
- Oystershell NV portfolio CI